The field of the present invention is infusion control systems.
Today, diabetes is understood to be reaching epidemic proportions in the United States. It remains as a worldwide problem as well. Diabetes brings with it a host of medical problems which are aggravated by conventional medicament dosage schemes. Traditional shots and the like are intermittent which can induce a cyclical plethora and paucity of medicament, typically insulin. Recent efforts have been undertaken to eliminate such harmful cyclical variations through continuous administration of medicament. Additionally, devices and controls have been designed to provide both a basal rate for sustained infusion and periodic boluses to accommodate the ingestion of carbohydrates. In spite of these advantageous capabilities, difficulties remain in accommodating the correct infusion regiment, clinician control and payer's oversight.
A wide variety of prior systems having applicable components and processes exist. Reference is made to U.S. Pat. Nos. 4,898,578; 5,205,819; 5,630,710; 6,852,104; and 7,018,360. Reference is also made to U.S. Patent Publications Nos. 2002/0029776; 2003/0032867; 2003/0163088; 2004/0220551; and 2005/0137573. The disclosures of the foregoing patents and patent publications are incorporated herein by reference.
In addition to the infusion of insulin for diabetes, infusion is useful for other purposes in bodies of both humans and animals. The types of liquids that can be delivered include, but are not limited to, insulin, antibiotics, nutritional fluids, total parenteral nutrition or TPN, analgestics, morphine, hormones or hormonal drugs, gene therapy drugs, anticoagulants, analgesics, cardiovascular medications, AZT and chemotherapeutics. The types of medical conditions treatable by infusion include, but are not limited to, diabetes, cardiovascular disease, pain, chronic pain, cancer, AIDS, neurological diseases, Alzheimer's Disease, ALS, Hepatitis, Parkinson's Disease or spasticity.
The present invention is directed to method and apparatus for infusing liquid to a body. Both contemplate the employment of an infusion device including a controller capable of programmable rate and time sequences. A separate programmable device is employed in the infusion system.
In a first separate aspect of the present invention, an infusion system includes the infusion device and a two-way communication device communicating with the controller through electrical contacts or a wireless link. A server system capable of communication with the two-way communication device through an extended area network has access to a file of information specific to the controller. The server system may also be capable of association with multiple two-way communication devices cooperating with multiple infusion devices.
In a second separate aspect of the present invention, an infusion system again includes the infusion device and a two-way communication device. A server system capable of communication with the two-way communication device has access to a file of information specific to the controller. The server system further includes at least one of a control terminal capable of inputting and changing the information specific to the controller in the file or a monitoring terminal capable of monitoring the inputting and changing of such operating instructions. Extended area network access for either of the control terminal and the monitoring terminal is also contemplated.
In a third separate aspect of the present invention, an infusion system again includes the infusion device and a two-way communication device. A server system capable of communication with the two-way communication device has access to a file of information specific to the controller. A wireless link incorporates a radio chip at the controller using a local area communication standard. The two-way communication device is capable of communicating with the radio chip. Such local area communication standards which may be employed are Bluetooth® NFC or Wibree™.
In a fourth separate aspect of the present invention, an infusion system again includes the infusion device and a two-way communication device. A server system capable of communication with the two-way communication device has access to a file of information specific to the controller. A wireless link incorporates a radio chip at the controller using a local area communication standard. The two-way communication device is capable of communicating with the radio chip using the local area communication standard. The two-way communication device employs one or both of voice and text communication.
In a fifth separate aspect of the present invention, an infusion system again includes the infusion device and a two-way communication device. A server system has access to a file of information specific to the controller. The two-way communication device is capable of communicating with the controller and the server system and is programmable by the server system over an extended area network. The network access may be through a wireless network link such as a cellular network, a wide area network or a combination of the two. Text messaging as well as voice communications are contemplated.
In a sixth separate aspect of the present invention, an infusion system again includes the infusion device and a two-way communication device. A server system capable of communication with the two-way communication device has access to a file of information specific to the controller. The infusion system further includes a sensor for generating a diagnostic signal. The sensor is in communication with either the controller or the two-way communication device for incorporation of the diagnostic signal into commands for operation of the controller.
In a seventh separate aspect of the present invention, an infusion system again includes the infusion device having a source of infusion fluid, a delivery port, a metering element and the controller capable of programmable infusion rate and time sequences. A programmable cell phone or PDA capable of two-way communication with the controller is used to control the infusion device.
In an eighth separate aspect of the present invention, an infusion device has a single use disposable assembly including a source of infusion fluid, a delivery port, a pump with a pump chamber and a movable pumping element. A multiuse assembly engageable with the single use disposable assembly has a pump driver extending to the movable pumping element and a controller capable of programmable infusion rate and time sequences. The disposable assembly and the multiuse assembly may each have a housing with an engagement and the pump driver has an actuator member extending to operatively engage the movable pumping element.
In a ninth separate aspect of the present invention, a method of infusing liquid to a body includes regulating infusion to the body using a programmable controller. A file of information specific to the controller is established and accessed by a network server system for transmitting operating instructions to a two-way communication device through an extended area network. The method further contemplates amending the information specific to the controller from a control terminal remote from the body. Requests for a bolus, a basal rate or other changes are input to the two-way communication device.
In a tenth separate aspect of the present invention, a method for infusing liquid to a body contemplates controlling infusion to the body using a programmable controller, establishing a file of information specific to the controller for transmitting commands from a network server through an extended area network to a two-way communication device. The method further contemplates amending operating instructions specific to the controller in the file from a control terminal remote from the body and providing network access through a monitoring terminal to monitor the incidents of amending operating instructions. Such monitoring can enable generation of payments to clinicians for the incidents of amending operating instructions.
In a eleventh separate aspect of the present invention, a method of infusing liquid to a body includes regulating infusion to the body using a programmable controller. A file of information specific to the controller is established and accessed by a network server system for transmitting operating instructions to a two-way communication device through a extended area network. The two-way communication device transmits commands to the controller through a local area wireless network interface. The method further contemplates amending the information specific to the controller from a control terminal remote from the body. A request for a bolus, a basal rate change or other input may be made to the two-way communication device. Commands are then transmitted to the controller responsive to the request. Data indicative of the magnitude of a constituent of liquid in the body is input to the server system.
In a twelfth separate aspect of the present invention, a method of infusing liquid to a body includes regulating infusion to the body using a programmable controller. A file of information specific to the controller is established and accessed by a network server system for transmitting operating instructions to a two-way communication device. The method further contemplates amending the operating instructions specific to the controller from a control terminal remote from the body and also contemplates inputting a request for a bolus or a basal rate change through the two-way communication device. Commands are transmitted from the two-way communication device to the controller responsive to the request for a bolus or a basal rate change. Transmitted operating instructions from the server system to the two-way communication device govern the commands response to input of a request for a bolus or basal rate change. The two-way communication device may be to a cellular telephone or a hand held computer with wireless data link and may include text messaging, voice communication or keypad input.
In a thirteenth separate aspect of the present invention, any of the foregoing aspects are contemplated to be combined to further advantage.
Accordingly, it is an object of the present invention to provide improved method and apparatus for the infusing of liquid to a body. Other and further objects and advantages will appear hereinafter.
Turning in detail to a preferred embodiment of a system for infusing liquid to a body, an infusion device, generally designated 10, includes a housing 12 conveniently circular in plan with a preferably low profile and a flat base. Shapes other than circular are also possible and the base may have some concavity for conformance to a body shape. With a circular shape, the housing 12 most conveniently defines an annular space 14 for a reservoir to provide a source of infusion fluid. The reservoir may be defined by the annular space 14 or may include an internal annular bladder 18 of PTFE or nonplasticized PVC with an elastomeric fill port 19. A circular opening 20 is centrally located in the top of the housing 12 with a recessed mounting flange 12 further includes an elastomeric overmold periphery and mounting surface 22 for soft edges and comfort. The infusion device 10 is intended to be placed on the skin of the body to be infused and held in place by such means as an adhesive coating 23, tape or other medical retaining system.
A metering element is provided in the housing 12. In the preferred embodiment, the metering element is a pump, generally designated 24. Other possibilities for the metering element include a valve to vent pressurized liquid or a single stroke piston dispensing through a restricted orifice. A central boss 25 concentrically located within the housing 12 defines a pump body with a pump chamber 26, an inlet 27 and an outlet 28. The pump formed thereby is conveniently centrally located within the housing 12 in this preferred embodiment. The pump includes two one-way valves 29, 30 each defined by a ball biased against a seat by a coil spring. A filter 31, which passes liquid but blocks gas, is located at the inlet 27.
A circular diaphragm 32 is shown extending across the central opening 20 of the housing 12 attached to the circular recessed mounting flange 21. The diaphragm 32 is resilient, being of elastomeric material and includes a centrally positioned integral piston 33. The piston 33, operating as a movable pumping element, extends to the pump chamber 26 formed in the central boss 25 to vary the chamber volume. The diaphragm 32 is in radial tension to create a restoring force to maintain the piston biased toward one end of its stroke in the pump chamber 26.
The housing 12, with the bladder 18, the pump 24 and a delivery port to the body defined by a rigid cannula 34, is considered disposable and is fabricated in an inexpensive manner. The delivery port 34 to the body contemplates single use. The capacity of the reservoir is intended to exceed the demand for medicament during the full term of use which may be some multiple of a twenty four hour period depending on the expected volume of use.
The infusion device 10 further includes a second housing 35 which is not considered disposable at the same rate as the housing 12 and has multiuse capability with a plurality of disposable housings 12. The second housing 35 is placed in the circular opening 20 and can be secured by an interference fit, interlocking flanges or a threaded engagement to define an engagement. The second housing 35 includes a pump driver 36, a pump controller 37 and a battery 38.
The pump driver 36 includes a mounting block 40 that retains an actuator arm 42 which is a laminated strip with one spring leaf and a piezoelectric strip that deforms the arm 42 when voltage is applied. An actuator member 43 at the end of the arm 42 extends from the arm 42 through the housing 35 to operatively engage the piston 33 of the diaphragm 32. The driver 36 acts in one direction to force the piston 33 into the pump chamber 26 while the tension in the diaphragm 32 drives the return stroke. Other drives include a screw oscillating about its axis to advance the piston using a nanomotor or magnetic contacts to drive the oscillations.
The battery 38 may be a conventional watch battery. Alternatively, a rechargeable battery may be employed which can be recharged by an induction charger or by more conventional means. The battery 38 powers the driver 36 through the controller 37.
The controller 37 is electronic and is programmable for delivering a range of infusion rates and timing of the sequences of actuation with a capability to oscillate power delivery from the battery 38 to the pump driver 36. Through this programming, a basal rate can be controlled as well as periodic boluses. The controller 37 also can provide device ID and monitor such parameters as battery life. Alarm modes and volume, timing of communication and other infusion device functions can be added to the function of the controller 37. Being programmable, a microcontroller with memory is integrated on a circuit board 44. Other elements included on the board(s) 44 as needed or advantageous include a battery monitoring circuit, a power switch, a DC/DC converter, a voltage regulator, an LED and driver, an alarm generator, a jack or antenna, an induction coil and a crystal reference with the microcontroller.
The controller 37 includes a wireless link 39 for communication to and from the controller 37 using a radio chip on the circuit board 44 to transceive commands to the controller and unit identify and device status from the controller 37. The radio chip 39 uses a local area communication standard. Bluetooth®, NFC and Wibree™ communication standards can be used, with NFC requiring greater proximity of the components for communication.
A programmable multi-function device capable of two-way communication with the controller 37 and separate from the infusion device 10 is employed for communication to the wireless link 39 using the local area communication standard. This device, as a two-way communication device 52, is in turn in communication with an extended area network. In the preferred embodiment, the two-way communication device 52 is a cellular telephone preferably with Java-enabled program capability. A hand held computer with a wireless data link such as a BlackBerry®, a Treo™ or other similar device, with the computer portion often identified as a “PDA”, is also contemplated. The phrase “two-way communication device” is intended to include all such possibilities while the terms “cellular phone” and its variations and the term “PDA” are intended to include those devices which access a public network for communication and data transfer. Such devices can advantageously download selected programs from the internet as may be used for glucose monitoring using a sensor or the like.
The extended area network with which the two-way communication device 52 is communicating may, therefore, be a cellular telephone network, a wide area network such as the internet or a private wide area network or a combination of technologies as systems become more integrated and the phrase “extended area network” is intended to include all such possibilities.
In a preferred embodiment, the protocol is through text communication, however, as, for example, diabetics can have vision problems as a symptom of that disease, voice communication to the two-way communication device 52 from the extended area network may be preferred. Response through the extended area network by cell phone keypad or voice would also be possible.
A server system 54 compatible with the extended area network is in selective communication with the two-way communication device 52 through the extended area network. This system 54 has access to a file of information specific to the controller 37. When connected through the extended area network, the server system 54 can provide operating instructions to the two-way communication device 52 for programming the controller 37 for infusion rate and timing sequences. The server system 54 may be employed to communicate in real time with the controller 37 through the extended area network and the wireless link 39 by relaying commands through the two-way communication device but more facilely can download programming and data to the programmable two-way communication device 52 for later and/or repeated communication with the controller 37.
The file of information specific to the controller accessible by the server system is accessible for creating and amending instructions from a control terminal 56. The control terminal is accessible by a clinician for inputting and changing the file through network access.
A monitoring terminal 58 can also be employed. The monitoring terminal 58 has limited access to the file of information specific to the controller. The terminal is intended to be employed by payers to service providers, e.g., medical insurance companies. The payer is anticipated to be interested in at least the incidents of inputting and changing of the file of information specific to the controller by the clinician. Additionally, the payer may be set to see the results of clinician control for purposes of evaluating the quality of service. In the case of diabetes, this may include the stability of a blood glucose level in the body of the infused person.
Blood glucose levels or other controlled constituents of liquid in the body may be measured and input to the server system 54. The monitoring can be undertaken by conventional testing means with the infused person reporting the diagnostics through the two-way communication device 52. Alternatively, a sensor 60 may automatically generate a diagnostic signal indicative of the magnitude of a detected substance relevant to the infusion such as blood glucose. A similar radio chip and battery may be employed in associated with the sensor 60. Alternatively, the sensor 60 may communicate through the wireless link radio chip 39 of the controller 37 and even share the same energy source 38. The diagnostic may be employed by the controller 37 directly, such as through a table downloaded as commands to the controller 37. A variable of the infusion device would be amended in accordance with the look-up table responsive to a magnitude of the diagnostic input. Alternatively, the diagnostic may be transmitted to the two-way communication device where a downloaded program from the server system employs the diagnostic to generate commands to the controller 37.
In addition to the foregoing, the same infusion system can serve multiple patients, each with an infusion device 10 and a two-way communication device 52. In this case, the server system 54 includes access to a multiple number of files of operating instructions. With a full medical service, many patients each wearing an infusion device 10 and communicating through a two-way communication device 52, multiple control terminals accesses by multiple clinicians and multiple monitoring terminals 58 serving multiple payers can function from the same server system 54. Safeguards are provided to insure the electronic communication appropriately addresses the correct infusion device and correct file of operating instructions. Dual identification handshakes, passwords and the like are programmed into the system.
Turning to system operation, a method for infusing liquid into a body is also presented.
In brief and looking to the Figures, the process of the patient interacting with the two-way communication device 52 begins with the patient inputting a request to the two-way communication device 52. In response, the two-way communication device 52 requests appropriate input. The input requested may be specifically responsive to the patient request or may follow certain repeated routines or both. The requested input may include blood glucose levels, anticipated carbohydrate intake, changes to settings, and the like. If the data is received, it is stored in the two-way communication device 52. In either event, the two-way communication device 52 generates appropriate commands as dictated by the program from the patient file, while commands are responsive to the patient request. The patient then accepts or rejects the change and, if accepted, the change is placed in the output queue. If rejected, the process is repeated.
The routine for the two-way communication device 52 to connect with a paired controller 37 is shown to include timing between the two. When the timing is correct, an attempt is made by the two-way communication device 52 with the controller 37 energized by synchronized timing to make contact. If the connection is made, the two-way communication device 52 downloads data from the output queue to the controller 37 and uploads status from the controller 37. If the status does not include an error flag, the process is recycled. If there are too many unsuccessful attempts to connect with the controller 37 or the status error flag is set, an alarm is activated. With a status error flag set in the controller 37, an alarm may be activated at the controller at that time. An alarm associated with the two-way communication device 52 and/or the server system 54 would be activated upon recognizing the status error flag or counting too many unsuccessful connection attempts.
The logic steps for use of the control terminal 56 is initiated by the clinician logging in. The appropriate file is retrieved and operating instructions are amended if the stored history, changes or new prescriptions are in place. The amendments are made and stored along with historical data. The clinician may further initiate automated billing for file charges and the process is complete.
For the communication between the server system 54 communicating with the two-way communication device 52, a time or incident initiation from either the two-way communication device 52 or the server system 54 initiates a connection. When connected, new and amended instructions are downloaded from the server system 54 to the two-way communication device 52 and data in the queue of the two-way communication device 52 is uploaded to the server system 54. When too much time is elapsed since the last connection, an alarm is set.
The operation of the monitor terminal 58 is initiated by a call to the server system 54. The monitor terminal 58 has read-only rights in the appropriate patient file accessed by the server system 54. The file is opened, a report is generated and the monitor terminal 58 logs off the system. With the monitor terminal 58 in the hands of a payer such as an insurance company, a bill can be generated based upon indication of clinician activity. Further, standard of care might also be evaluated if access is given to the historical data.
The programmable controller 37 is employed to control infusion into the body. To undertake that control, a file of information specific to the controller 37 is established and accessible to the server system 54. The server system 54 is associated with the extended area network preferably national or international in scope such as employs internet or cell phone technology. The server system 54 preferably has access to a great many files of information specific to controllers 37 to serve a large number of infusion patients. All such patients may be served over the extended area network to their individual two-way communication devices 52. From the server system 54, operating instructions including programming are transmitted over the extended area network to two-way communication devices 52. In the preferred embodiment above, the two-way communication devices 52 are Java-enabled cell phones with the extended area network being a cellular or satellite telephone network.
The creation or modification of information specific to a patient infusion device 10 is accomplished through the control terminal 56 by amending the updatable file of operating instructions. This function is illustrated in the logic diagram of
With the use of a programmable two-way communication device 52, the server system 54 may download programming including operating instructions at regular or requested intervals to the two-way communication device 52. This function is illustrated in the logic diagram of
The patient input includes secure identification and may be undertaken using keypad input or voice communication to the programmable cell phone 52 or to the other devices discussed above. The two-way communication device 52 can then prompt, orally or visually, for the necessary input. Such input appropriately would include the estimated amount of carbohydrates in the case of diabetics which have just been ingested or are to be ingested for a bolus. Periodically current blood glucose level can be demanded of or voluntarily submitted by the patient to be entered manually from patient testing or automatically on a periodic basis from a sensor 60. These functions are seen in the logic diagram of
The requested basal rate changes and bolus requests input to the two-way communication device 52 are transmitted as program commands. The commands are sent through the wireless link 39 to the programmable controller 37. The commands for implementation are maintained within the boundaries of discretion dictated by the operating instructions to the two-way communication device 52 from the patient file accessible by the server system 54.
Currency is also maintained in the patient file accessible to the server system 54 by return from the two-way communication device 52 of data regarding the history of requests, rate changes, boluses administered, recorded changes in constituent fluid status, system and component status and other possible input such as demographics or diabetes centers. Such information is useful to the clinician for subsequent treatment and to any analysis of treatment efficacy. This input from the two-way communication device 52 may follow some period of operation independent of the server system 54 or be timed to more closely monitor patients in unstable circumstances. The server system 54 can also generate automatic alerts to clinicians when malfunctions are sensed or boundary values are exceeded as discussed below. The system is designed to check periodically as well as be connected when requests or changes are made.
The monitoring of care of a patient and efficacy of the treatment can be undertaken from analysis of the patient file from any authorized terminal. This function is illustrated in the logic diagram of
Communication between the controller and the two-way communication device is arranged to conserve battery power in the infusion device. Rather than have the wireless link prepared to receive communication from the two-way communication device at any time, the two-way communication device and controller sync clocks each time they do communicate. Further, a time interval, say five minutes, is set when the controller is to turn on the wireless link and the two-way communication device sends a signal to the controller. The signal may be the initiation of a change in infusion rate and/or sequence or communication of infusion device status and a further sync of the clocks for another period, thereby setting up scheduled data shuttles. The logic steps for this operation are illustrated in
When the user requests a change or the server downloads a change to the two-way communication device under the battery conservation scheme, the two-way communication device is scheduled for a download to the controller. At the appointed interval, the controller switches on and the two-way communication device transmits the change to the controller. Where control is time critical, a short time interval can be used for the scheduled data shuttles.
The schedule may be used to monitor and signal concern. If the communication device fails to establish a connection to the controller through the wireless link after a preprogrammed number of tries, the two-way communication device will alert the user through an audio or vibrational alarm as the infusion device has either malfunctioned, including having a dead battery, or the device is out of range of the two-way communication device.
A further failsafe mechanism can be implemented by requiring the two-way communication device to signal the server on a regular basis that communication to the infusion device is maintained and that an error-free status byte has been received. If the server does not receive this information, either the infusion device has failed or is out of range of the two-way communication device or the two-way communication device has failed or is out of range of any transfer station. The server can then send an alert such as by calling an emergency number.
Thus, an improved method and apparatus for the infusion of liquid to a body is disclosed. While embodiments and applications of this invention have been shown and described, it would be apparent to those skilled in the art that many more modifications are possible without departing from the inventive concepts herein. The invention, therefore it not to be restricted except in the spirit of the appended claims.
Number | Name | Date | Kind |
---|---|---|---|
4221219 | Tucker | Sep 1980 | A |
4231019 | Junginger et al. | Oct 1980 | A |
4373527 | Fischell | Feb 1983 | A |
4449893 | Beckman et al. | May 1984 | A |
4468221 | Mayfield | Aug 1984 | A |
4469481 | Kobayashi | Sep 1984 | A |
4565542 | Berg | Jan 1986 | A |
4596575 | Rosenberg et al. | Jun 1986 | A |
4650469 | Berg et al. | Mar 1987 | A |
4685903 | Cable et al. | Aug 1987 | A |
4734092 | Millerd | Mar 1988 | A |
4871351 | Feingold | Oct 1989 | A |
4886499 | Cirelli et al. | Dec 1989 | A |
4898578 | Rubalcaba, Jr. | Feb 1990 | A |
4944659 | Labbe et al. | Jul 1990 | A |
5085562 | van Lintel | Feb 1992 | A |
5205819 | Ross et al. | Apr 1993 | A |
5219278 | van Lintel | Jun 1993 | A |
5224843 | van Lintel | Jul 1993 | A |
5271724 | van Lintel | Dec 1993 | A |
5277556 | van Lintel | Jan 1994 | A |
5328460 | Lord et al. | Jul 1994 | A |
5338157 | Blomquist | Aug 1994 | A |
5376070 | Purvis | Dec 1994 | A |
5433710 | Van Antwerp | Jul 1995 | A |
5443508 | Giampapa | Aug 1995 | A |
5480386 | Brohy et al. | Jan 1996 | A |
5485408 | Blomquist | Jan 1996 | A |
5507737 | Palmskog | Apr 1996 | A |
5569186 | Lord et al. | Oct 1996 | A |
5569187 | Kaiser | Oct 1996 | A |
5575770 | Melsky et al. | Nov 1996 | A |
5582593 | Hultman | Dec 1996 | A |
5630710 | Tune et al. | May 1997 | A |
5637095 | Nason et al. | Jun 1997 | A |
5658250 | Blomquist et al. | Aug 1997 | A |
5665070 | McPhee | Sep 1997 | A |
5695473 | Olsen | Dec 1997 | A |
5707361 | Slettenmark | Jan 1998 | A |
5725363 | Bustgens et al. | Mar 1998 | A |
5759014 | Van Lintel | Jun 1998 | A |
5759015 | Van Lintel et al. | Jun 1998 | A |
5761782 | Sager | Jun 1998 | A |
5764159 | Neftel | Jun 1998 | A |
5773913 | Casselden | Jun 1998 | A |
5788669 | Peterson | Aug 1998 | A |
5798600 | Sager et al. | Aug 1998 | A |
5807375 | Gross et al. | Sep 1998 | A |
5810015 | Flaherty | Sep 1998 | A |
5848991 | Gross et al. | Dec 1998 | A |
5858005 | Kriesel | Jan 1999 | A |
5931814 | Alex et al. | Aug 1999 | A |
5935099 | Peterson et al. | Aug 1999 | A |
5954058 | Flaherty | Sep 1999 | A |
5957890 | Mann et al. | Sep 1999 | A |
5957895 | Sage et al. | Sep 1999 | A |
5961492 | Kriesel et al. | Oct 1999 | A |
5997263 | Van Lintel et al. | Dec 1999 | A |
5997501 | Gross et al. | Dec 1999 | A |
6106498 | Friedli et al. | Aug 2000 | A |
6174300 | Kriesel et al. | Jan 2001 | B1 |
6237619 | Maillefer et al. | May 2001 | B1 |
6248093 | Moberg | Jun 2001 | B1 |
6259587 | Sheldon et al. | Jul 2001 | B1 |
6309189 | Rey-Mermet et al. | Oct 2001 | B1 |
6375638 | Nason et al. | Apr 2002 | B2 |
6390791 | Maillefer et al. | May 2002 | B1 |
6423035 | Das et al. | Jul 2002 | B1 |
6458102 | Mann et al. | Oct 2002 | B1 |
6461331 | Van Antwerp | Oct 2002 | B1 |
6485461 | Mason et al. | Nov 2002 | B1 |
6488652 | Weijand et al. | Dec 2002 | B1 |
6585695 | Adair et al. | Jul 2003 | B1 |
6589229 | Connelly et al. | Jul 2003 | B1 |
6589299 | Missling et al. | Jul 2003 | B2 |
6595756 | Gray et al. | Jul 2003 | B2 |
6645142 | Braig et al. | Nov 2003 | B2 |
6656148 | Das et al. | Dec 2003 | B2 |
6656158 | Mahoney et al. | Dec 2003 | B2 |
6656159 | Flaherty | Dec 2003 | B2 |
6669669 | Flaherty et al. | Dec 2003 | B2 |
6692457 | Flaherty | Feb 2004 | B2 |
6699218 | Flaherty et al. | Mar 2004 | B2 |
6716002 | Higashino | Apr 2004 | B2 |
6719739 | Verbeek et al. | Apr 2004 | B2 |
6723072 | Flaherty et al. | Apr 2004 | B2 |
6740059 | Flaherty | May 2004 | B2 |
6740072 | Starkweather et al. | May 2004 | B2 |
6749587 | Flaherty | Jun 2004 | B2 |
6752787 | Causey et al. | Jun 2004 | B1 |
6768425 | Flaherty et al. | Jul 2004 | B2 |
6770067 | Lorenzen et al. | Aug 2004 | B2 |
6774437 | Bryant et al. | Aug 2004 | B2 |
6809653 | Mann et al. | Oct 2004 | B1 |
6827559 | Peters et al. | Dec 2004 | B2 |
6827702 | Libel et al. | Dec 2004 | B2 |
6830558 | Flaherty et al. | Dec 2004 | B2 |
6843782 | Gross et al. | Jan 2005 | B2 |
6852104 | Blomquist | Feb 2005 | B2 |
6878132 | Kipfer | Apr 2005 | B2 |
6948918 | Hansen | Sep 2005 | B2 |
6960192 | Flaherty et al. | Nov 2005 | B1 |
6974437 | Lebel et al. | Dec 2005 | B2 |
6986649 | Dai et al. | Jan 2006 | B2 |
6997921 | Gray et al. | Feb 2006 | B2 |
7005078 | Van Lintel et al. | Feb 2006 | B2 |
7018360 | Flaherty et al. | Mar 2006 | B2 |
7052251 | Nason et al. | May 2006 | B2 |
7107086 | Reihl et al. | Sep 2006 | B2 |
7115111 | Haindl | Oct 2006 | B2 |
7122005 | Shusterman | Oct 2006 | B2 |
7128727 | Flaherty et al. | Oct 2006 | B2 |
7128730 | Marano-Ford et al. | Oct 2006 | B2 |
7137964 | Flahery | Nov 2006 | B2 |
7141023 | Diermann et al. | Nov 2006 | B2 |
7144384 | Gorman et al. | Dec 2006 | B2 |
7179226 | Crothall et al. | Feb 2007 | B2 |
7186236 | Gibson et al. | Mar 2007 | B2 |
7193521 | Moberg et al. | Mar 2007 | B2 |
7195609 | Huegli | Mar 2007 | B2 |
7204823 | Estes et al. | Apr 2007 | B2 |
7218968 | Condie et al. | May 2007 | B2 |
7255690 | Gray et al. | Aug 2007 | B2 |
7258253 | Nicol et al. | Aug 2007 | B2 |
7268466 | Rasmussen | Sep 2007 | B2 |
7275522 | Beilharz et al. | Oct 2007 | B2 |
7284474 | Eigemann et al. | Oct 2007 | B2 |
7284962 | Blakey | Oct 2007 | B2 |
7287965 | Vogeley et al. | Oct 2007 | B2 |
7290993 | Vogeley et al. | Nov 2007 | B2 |
7291107 | Hellwig et al. | Nov 2007 | B2 |
7297111 | Iliff | Nov 2007 | B2 |
7300402 | Iliff | Nov 2007 | B2 |
7303549 | Flaherty et al. | Dec 2007 | B2 |
7306560 | Iliff | Dec 2007 | B2 |
20020029776 | Blomquist | Mar 2002 | A1 |
20020040208 | Flaherty et al. | Apr 2002 | A1 |
20020072733 | Flaherty | Jun 2002 | A1 |
20030014011 | Robert | Jan 2003 | A1 |
20030032867 | Crothall | Feb 2003 | A1 |
20030050626 | Gibson et al. | Mar 2003 | A1 |
20030055380 | Flaherty | Mar 2003 | A1 |
20030163088 | Blomquist | Aug 2003 | A1 |
20040078028 | Flaherty et al. | Apr 2004 | A1 |
20040092873 | Moberg | May 2004 | A1 |
20040116866 | Gorman et al. | Jun 2004 | A1 |
20040158230 | Hunn et al. | Aug 2004 | A1 |
20040204673 | Flaherty | Oct 2004 | A1 |
20040220551 | Flaherty et al. | Nov 2004 | A1 |
20040235446 | Flaherty et al. | Nov 2004 | A1 |
20040260233 | Garibotto et al. | Dec 2004 | A1 |
20050022274 | Campbell et al. | Jan 2005 | A1 |
20050043676 | Remde et al. | Feb 2005 | A1 |
20050065464 | Talbot et al. | Mar 2005 | A1 |
20050065760 | Murtfeldt et al. | Mar 2005 | A1 |
20050090808 | Malave et al. | Apr 2005 | A1 |
20050137573 | McLaughlin | Jun 2005 | A1 |
20050159708 | Sidler | Jul 2005 | A1 |
20050171512 | Flaherty | Aug 2005 | A1 |
20050177137 | Kipfer | Aug 2005 | A1 |
20050182366 | Vogt et al. | Aug 2005 | A1 |
20050182391 | Schiltges et al. | Aug 2005 | A1 |
20050197625 | Haueter et al. | Sep 2005 | A1 |
20050215982 | Malave et al. | Sep 2005 | A1 |
20050222645 | Malave et al. | Oct 2005 | A1 |
20050238507 | DiIanne et al. | Oct 2005 | A1 |
20050273080 | Paul | Dec 2005 | A1 |
20060031094 | Cohen et al. | Feb 2006 | A1 |
20060036134 | Tarassenko et al. | Feb 2006 | A1 |
20060041229 | Garibotto et al. | Feb 2006 | A1 |
20060047192 | Hellwig et al. | Mar 2006 | A1 |
20060047538 | Condurso et al. | Mar 2006 | A1 |
20060074381 | Malave et al. | Apr 2006 | A1 |
20060116664 | Richter et al. | Jun 2006 | A1 |
20060137695 | Hellwig et al. | Jun 2006 | A1 |
20060178633 | Garibotto et al. | Aug 2006 | A1 |
20060282290 | Flaherty et al. | Dec 2006 | A1 |
20070118405 | Campbell et al. | May 2007 | A1 |
20070129688 | Scheurer et al. | Jun 2007 | A1 |
20070166181 | Nilson | Jul 2007 | A1 |
20070181425 | Kim | Aug 2007 | A1 |
20070219480 | Kamen et al. | Sep 2007 | A1 |
20070233206 | Frikart et al. | Oct 2007 | A1 |
20070251835 | Mehta et al. | Nov 2007 | A1 |
20070253021 | Mehta | Nov 2007 | A1 |
20070253380 | Jollota et al. | Nov 2007 | A1 |
20070254593 | Jollota et al. | Nov 2007 | A1 |
20070255116 | Mehta et al. | Nov 2007 | A1 |
20070255126 | Moberg et al. | Nov 2007 | A1 |
20070255250 | Moberg et al. | Nov 2007 | A1 |
20070255348 | Holtzclar | Nov 2007 | A1 |
20070258395 | Jollota et al. | Nov 2007 | A1 |
20080119705 | Patel et al. | May 2008 | A1 |
Number | Date | Country |
---|---|---|
1 837 787 | Sep 2007 | EP |
Number | Date | Country | |
---|---|---|---|
20080086086 A1 | Apr 2008 | US |